C. Chougnet

2.6k total citations
36 papers, 1.6k citations indexed

About

C. Chougnet is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, C. Chougnet has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in C. Chougnet's work include Thyroid Cancer Diagnosis and Treatment (20 papers), Neuroendocrine Tumor Research Advances (14 papers) and Thyroid and Parathyroid Surgery (9 papers). C. Chougnet is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (20 papers), Neuroendocrine Tumor Research Advances (14 papers) and Thyroid and Parathyroid Surgery (9 papers). C. Chougnet collaborates with scholars based in France, United States and Denmark. C. Chougnet's co-authors include Sophie Leboulleux, Éric Baudin, Martin Schlumberger, Isabelle Borget, Caroline Caramella, Désirèe Deandreis, Abir Al Ghuzlan, Jean‐Yves Scoazec, Julien Hadoux and Jorge Barriuso and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

C. Chougnet

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Chougnet France 17 813 794 689 574 479 36 1.6k
Joakim Crona Sweden 21 523 0.6× 446 0.6× 778 1.1× 454 0.8× 946 2.0× 58 1.6k
Maria A. Kouvaraki United States 14 770 0.9× 842 1.1× 637 0.9× 534 0.9× 504 1.1× 23 1.7k
김나래 2 445 0.5× 412 0.5× 559 0.8× 248 0.4× 358 0.7× 3 1.0k
A. Berdelou France 19 337 0.4× 367 0.5× 536 0.8× 231 0.4× 350 0.7× 35 1.0k
Jaydira Del Rivero United States 17 269 0.3× 360 0.5× 328 0.5× 201 0.4× 408 0.9× 83 987
J A van Heerden United States 13 386 0.5× 590 0.7× 178 0.3× 132 0.2× 344 0.7× 15 904
Cathérine De Micco France 19 224 0.3× 199 0.3× 773 1.1× 82 0.1× 440 0.9× 24 1.1k
Edina Paál United States 13 253 0.3× 420 0.5× 151 0.2× 122 0.2× 366 0.8× 29 1.0k
Nitya Raj United States 15 563 0.7× 610 0.8× 63 0.1× 403 0.7× 173 0.4× 63 843
Virginia Cappagli Italy 18 216 0.3× 308 0.4× 868 1.3× 46 0.1× 233 0.5× 38 1.1k

Countries citing papers authored by C. Chougnet

Since Specialization
Citations

This map shows the geographic impact of C. Chougnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Chougnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Chougnet more than expected).

Fields of papers citing papers by C. Chougnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Chougnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Chougnet. The network helps show where C. Chougnet may publish in the future.

Co-authorship network of co-authors of C. Chougnet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Chougnet. A scholar is included among the top collaborators of C. Chougnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Chougnet. C. Chougnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lasolle, Hélène, Livia Lamartina, Camille Buffet, et al.. (2024). Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network. Endocrine Abstracts. 1 indexed citations
2.
Fouchardière, Christelle de la, Yann Godbert, Cécile Dalban, et al.. (2021). Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR. European Journal of Cancer. 157. 153–164. 11 indexed citations
3.
Newbold, K., Baktiar Hasan, Laura D. Locati, et al.. (2020). 1919P Nintedanib (BIBF1120) after first line therapy in progressive medullary thyroid cancer: A multicenter EORTC prospective randomized double-blind phase II study (NCT01788982). Annals of Oncology. 31. S1087–S1088. 1 indexed citations
4.
Rozenblum, Laura, Fatima‐Zohra Mokrane, Randy Yeh, et al.. (2019). Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach. European Journal of Radiology. 122. 108743–108743. 8 indexed citations
5.
Méas, T., et al.. (2018). Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience. European Thyroid Journal. 7(3). 149–154. 3 indexed citations
6.
Berdelou, A., Isabelle Borget, Yann Godbert, et al.. (2017). Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice. Thyroid. 28(1). 72–78. 102 indexed citations
7.
Berdelou, A., Valérie Boige, Julia Arfi‐Rouche, et al.. (2016). Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study. Neuroendocrinology. 105(1). 26–34. 12 indexed citations
8.
Chougnet, C., Ingrid Holst Olsen, Anja Rinke, et al.. (2015). Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocrine Related Cancer. 22(4). 657–664. 277 indexed citations
9.
Brassard, Maryse, Isabelle Borget, F. Bonichon, et al.. (2014). Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. European Journal of Endocrinology. 170(4). 575–582. 81 indexed citations
10.
Bernard, Valérie, C. Chougnet, Florence Tenenbaum, & Jacques Young. (2014). 131I-Noriodocholesterol Uptake by Testicular Adrenal Rest Tumors in a Patient With Classical 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism. 99(11). 3956–3957. 3 indexed citations
11.
Vélayoudom‐Céphise, Fritz‐Line, Pierre Duvillard, L. Foucan, et al.. (2013). Are G3 ENETS neuroendocrine neoplasms heterogeneous?. Endocrine Related Cancer. 20(5). 649–657. 244 indexed citations
12.
Bernard, Valérie, Catherine Lombard‐Bohas, François‐Xavier Caroli‐Bosc, et al.. (2013). Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. European Journal of Endocrinology. 168(5). 665–674. 81 indexed citations
13.
Borget, Isabelle, Frédéric Troalen, Abir Al Ghuzlan, et al.. (2013). Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation. European Journal of Endocrinology. 169(5). 689–693. 49 indexed citations
14.
Chougnet, C., Sophie Leboulleux, Caroline Caramella, et al.. (2013). Frequency and characterization of gastro–entero–pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy. Endocrine Related Cancer. 20(2). 229–239. 10 indexed citations
15.
Ayala‐Ramirez, Montserrat, C. Chougnet, Mouhammed Amir Habra, et al.. (2012). Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas. The Journal of Clinical Endocrinology & Metabolism. 97(11). 4040–4050. 144 indexed citations
16.
Caldérari, Sophie, C. Chougnet, Maud Clemessy, et al.. (2012). Angiopoietin 2 Alters Pancreatic Vascularization in Diabetic Conditions. PLoS ONE. 7(1). e29438–e29438. 15 indexed citations
17.
Schlumberger, Martin, et al.. (2012). Kinase inhibitors for advanced medullary thyroid carcinoma. Clinics. 67. 125–129. 12 indexed citations
18.
Baudin, Eric, Sophie Leboulleux, Abir Al Ghuzlan, et al.. (2011). Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?. Hormones and Cancer. 2(6). 363–371. 29 indexed citations
19.
Schlumberger, Martin, C. Chougnet, Éric Baudin, & Sophie Leboulleux. (2011). Cancers réfractaires de la thyroïde. La Presse Médicale. 40(12). 1189–1198. 7 indexed citations
20.
Borget, Isabelle, Abir Al Ghuzlan, Désirèe Deandreis, et al.. (2010). Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocrine Related Cancer. 18(2). R29–40. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joakim Crona Breakdown of academic impact, for papers by Maria A. Kouvaraki Breakdown of academic impact, for papers by 김나래 Breakdown of academic impact, for papers by A. Berdelou Breakdown of academic impact, for papers by Jaydira Del Rivero Breakdown of academic impact, for papers by J A van Heerden Breakdown of academic impact, for papers by Cathérine De Micco Breakdown of academic impact, for papers by Edina Paál Breakdown of academic impact, for papers by Nitya Raj Breakdown of academic impact, for papers by Virginia Cappagli
Rankless by CCL
2026